Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

PACS Group, Inc. (PACS) Guidance & Earnings Results

On 2026-08-04 PACS Group, Inc. raised guidance: "FY2026 Adjusted EBITDA $640-$660M (from $605-$625M); Revenue $5.75-$5.85B (from…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

PACSPACS Group, Inc.Follow PACS — free
Medical Care Facilities · Healthcare
—
Price chart with a free account
Market cap
7.5B
P/E TTM
27.9
Dividend yield
—
52-week
—
Next earnings
17 Nov, in 24 days

What management guided

each earnings 8-K · figures checked against the filing text
ReleaseDirectionWhat they said
4 Aug 26RaisedFY2026 Adjusted EBITDA $640-$660M (from $605-$625M); Revenue $5.75-$5.85B (from $5.65-$5.75B) · full year
11 May 26RaisedFull-year 2026 Adj. EBITDA guidance raised to $605-625M from $555-575M · full year
26 Feb 26Raised2026 revenue $5.65-5.75B, EBITDA $555-575M · full year
19 Nov 25RaisedFY2025 revenue $5.25-5.35B, Adj. EBITDA $480-490M · full year

PACS Group, Inc. — questions

What guidance did PACS Group, Inc. give?
On 2026-08-04: "FY2026 Adjusted EBITDA $640-$660M (from $605-$625M); Revenue $5.75-$5.85B (from $5.65-$5.75B)"
When does PACS Group, Inc. report earnings?
PACS Group, Inc.'s next earnings report is expected on 2026-11-17.

Every figure on this page comes from PACS Group, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.